Your browser is no longer supported. Please, upgrade your browser.
Settings
PBE PowerShares Dynamic Biotech & Genome ETF daily Stock Chart
PBE [NYSE]
PowerShares Dynamic Biotech & Genome ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week-1.97%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-0.68%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter3.69%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio0.18 Perf Half Y17.06%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year25.61%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range35.64 - 51.17 Perf YTD26.62%
Dividend0.39 P/FCF- EPS past 5Y- ROI- 52W High-4.28% Beta-
Dividend %0.79% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low37.41% ATR0.55
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)45.59 Volatility1.23% 1.15%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.37 Prev Close49.14
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume21.78K Price48.98
Recom- SMA20-1.76% SMA500.93% SMA2009.83% Volume7,540 Change-0.32%
Sep-21-17 02:13PM  Gene-Editing Could Modify and Cure Disease: CRISPR vs. TALENs Harvest Exchange
11:56AM  A Shot in the Arm for the UK Life Sciences Industry? Harvest Exchange
Sep-12-17 09:06AM  How Did Gileads Blockbuster Drug Harvoni Perform in 2Q17? Market Realist
Aug-23-17 04:18PM  Whats Ionis Pharmaceuticals Valuation? Market Realist
Jul-10-17 02:35PM  What Drove Biogen Stock in 2Q17? Market Realist
Jun-14-17 03:04PM  How Incytes Valuation Has Changed since 1Q17 Results Market Realist
Jun-09-17 04:47PM  Changes in Ionis Pharmaceuticals Valuation after 1Q17 Market Realist
May-05-17 05:16PM  ETF Flopper: Biotech Bungle Barrons.com
Mar-13-17 05:46PM  Time to Buy Biotech ETFs?
05:46PM  Time to Buy Biotech ETF? Zacks
Mar-02-17 02:00PM  Trump's Immigration Plans an Overhang on Biotech ETFs? Zacks
Mar-01-17 09:06AM  A Look at Incytes Product Portfolio Market Realist
09:06AM  A Look at Incytes Product Portfolio
Jan-27-17 04:30PM  What Lies Ahead for Biotech ETFs in Trump Era? Zacks
Jan-12-17 10:08AM  Trump Attacks Biotech & Pharma: ETFs Bleed Zacks
Jan-09-17 07:36AM  Whats in Incytes Product Portfolio? Market Realist
07:36AM  Whats in Incytes Product Portfolio?
Dec-15-16 01:04PM  POWERSHARES EXCHANGE TRADED FUND TRUST Financials
Dec-02-16 10:04AM  Neurocrine Biosciences Pursues Womens Health Segment with Elagolix Market Realist
10:04AM  Neurocrine Biosciences Pursues Womens Health Segment with Elagolix
Nov-08-16 03:26PM  Biotech ETFs Slumping on Q3 Results Zacks
Oct-27-16 12:19PM  4 Frightful ETFs of This Year Zacks
Oct-11-16 08:04AM  How Did Gileads Other Products Perform in 2Q16?
Oct-07-16 01:16PM  Is the Dividend ETF Bull Run Over?
Oct-05-16 09:42AM  3 ETFs to Buy for a Media Merger Frenzy
Sep-01-16 11:04AM  How Are Eli Lillys Business Segments Performing?
Aug-31-16 03:39PM  Biotech ETF Industry Outlook
Aug-24-16 10:04AM  Why Did Hormel Foods Increase Its Fiscal 2016 Guidance?
Aug-23-16 09:30AM  The Zacks Analyst Blog Highlights: PureFunds ISE Junior Silver ETF, SPDR S&P Technology Hardware ETF, PowerShares Dynamic Semiconductors ETF, SPDR S&P Health Care Services ETF and PowerShares DWA Utilities Momentum ETF
Aug-04-16 09:47AM  Top Tech ETFs Of 2016
Jul-27-16 11:57AM  This Seasonal ETF Is Ripe For The Pickin' This Summer
Jul-25-16 09:20AM  A Consumer Staples ETF To Feast On
Jul-23-16 12:00PM  Restaurants Reflect Consumption Trends (Literally)
Jul-12-16 05:05PM  Why Are So Many Analysts Rating B&G Foods a Hold?
Jul-11-16 10:05AM  Why Did BioMarins Share Price Tank after Brexit?
Jul-05-16 10:53AM  Top and Flop Sector ETFs YTD
Jun-29-16 05:09PM  Inside Neurocrine Biosciences Analyst Recommendations in 2016
10:59AM  Why Did Cal-Maine Shares Fall 23% in the Last 3 Months?
Jun-10-16 09:06AM  An Inside Look at Incytes Product Portfolio
May-13-16 04:48PM  What Lies Ahead for Biotech ETFs?
May-11-16 06:05AM  Hain Celestial Traded above Key Moving Averages
May-04-16 09:00AM  Finding Pharmaceuticals ETFs With Rebound Potential
Apr-07-16 04:04PM  How Does Incytes Valuation Compare to Peers?
Mar-18-16 08:20AM  Potent Value In This Large-Cap ETF
Mar-09-16 06:37AM  5 Best Performing Bull Run Equity ETFs
Mar-01-16 11:27PM  Worst Performing ETFs Of 2016 To Date
Jan-22-16 09:31AM  2 ETFs That Surged to Rank #1 Braving All Odds
Jan-21-16 06:18PM  Consumer Discretionary ETFs Rise But Starbucks Cools at Investor's Business Daily
Jan-13-16 12:09PM  Why Did the US Halt Bunges Canola Meal Shipment? -6.11%
Jan-11-16 01:38PM  An ETF For Growth With A Broad Supporting Cast
Jan-08-16 02:10PM  Deutsche Bank Downgrades Mondelz International
Jan-05-16 07:49PM  Pharmaceutical ETFs Perk Up As Stock Market Stays Skittish at Investor's Business Daily
Jan-04-16 08:38AM  Head To The Polls With This ETF In 2016
Dec-24-15 04:48PM  How Does Cal-Maine Foods Compare to Its Peers?
09:59AM  Meet This Year's Best Industrial ETF
Dec-21-15 12:22PM  Top 10 Smart Beta ETFs Of 2015
Dec-08-15 08:20AM  How Did Marvell Technology Group Compare to Its Peers? Market Realist
Dec-03-15 10:29AM  How Does American Eagle Outfitters Compare to Its Peers?
08:02AM  How Does Synopsys Compare to Its Peers?
Dec-01-15 10:07AM  A Fund Flow and Volume Analysis of ICF and PJP
Nov-30-15 01:38PM  A Structural Analysis of Smart Beta Fund ICF
Nov-23-15 08:24PM  Pharma ETFs Pop Amid Pfizer-Allergan $160 Bil Deal at Investor's Business Daily
06:05PM  How Did Nuance Communications Perform in Comparison to Its Peers?
01:25PM  How Did Foot Locker Perform Compared to Its Peers?
Nov-20-15 06:08PM  The Best Healthcare ETF of the Week at Motley Fool
03:53PM  How Has PBE Performed in the Market This Year?
03:53PM  A Must-Read Structural Overview of PBE
Nov-18-15 06:11AM  The PowerShares Dynamic Pharmaceuticals ETF: Holdings Breakdown
06:11AM  Comparing the PowerShares Dynamic Biotechnology & Genome Portfolio with PJP
Nov-12-15 01:11PM  The PowerShares Dynamic Pharmaceuticals ETF: Key Overview
01:06PM  The PowerShares Dynamic Pharmaceuticals ETF: PJPs 2015 Performance
08:14AM  How Did Flowers Foods Perform Compared to Peers and ETFs?
Nov-11-15 02:33PM  This Tech ETF Has Almost Doubled In Size In A Month
Nov-10-15 06:17AM  How To Avoid The Pharmaceuticals Fallout With These Three ETFs
Nov-06-15 09:10AM  ANSYSs Revenue and Income Rose in 3Q15
Nov-04-15 02:46PM  Smart Beta Fund PTH Showed Strong Growth in 3Q15
Oct-31-15 11:07AM  Analyst Recommendations for Check Point Software in 3Q15
Oct-29-15 06:55AM  These ETFs Should Love The Pfizer-Allergan News
Oct-28-15 01:36PM  Halloween Effect: ETFs That Would Not Scare You
Oct-27-15 07:36PM  How Does Cadence Design Compare to Its Peers?
06:10PM  Pharma ETFs Gain On Pfizer; Apple Rises After Hours at Investor's Business Daily
Oct-26-15 02:40PM  Problem Children Aren't Derailing Consumer Staples ETFs
Oct-22-15 03:48PM  How Does Interpublic Group of Companies Compare to Its Peers?
12:12PM  Pharma ETFs : Mergers & Deals Remain in Focus
Oct-13-15 07:22PM  A Comparative Analysis of Smart Beta Funds
Oct-07-15 02:50PM  Value ETFs May Get Their Day In The Sun
09:07AM  How Does Barracuda Networks Compare to Its Peers?
Oct-02-15 01:27PM  How Does Progress Software Compare to Its Peers?
01:27PM  Progress Software: Organic Growth Boost the Revenue
01:27PM  How Did Micron Technology Perform Compared to Its Peers?
09:08AM  How Does Costco Compare to Its Peers?
Oct-01-15 02:07AM  How Has Scholastic Performed Compared to Its Peers?
Sep-29-15 10:48AM  Why Scholastics Net Income Fell in 1Q16
Sep-23-15 07:00AM  This Is the Best ETF of the Past 10 Years
Sep-16-15 11:42AM  The Comprehensive Guide to Biotech ETFs
Sep-14-15 12:56PM  How Palo Alto Networks Performed Compared to Its Peers Market Realist
12:56PM  How Does Kroger Compare to Its Competitors?
Sep-08-15 12:06PM  Comparing PTH to Its Peers, PBE and PJP
Sep-02-15 12:54PM  The Complete Guide to Retail ETFs
Aug-30-15 08:28PM  Dialing Up Communications ETFs
The investment seeks to track the investment results (before fees and expenses) of the Dynamic Biotech & Genome IntellidexSM Index. The fund generally will invest at least 90% of its total assets in common stocks of biotechnology companies and genome companies that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of 30 U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.